The company manufactures diamond-studded gold jewelry and trades in cut and polished diamonds, while also engaging in real estate development and land trading.
The company operates in a highly fragmented and commoditized market with no evidence of brand power or cost advantages. Financial metrics show extremely low and unstable returns on capital, and the lack of revenue in the real estate segment for several years suggests a failed or dormant diversification strategy.
Capital is primarily tied up in inventory and related-party advances rather than productive assets. The company has failed to generate meaningful returns for shareholders, and recent plans to issue warrants were stalled due to a lack of funds to even pay regulatory filing fees.
The company's collapse was precipitated by its chronic inability to fund basic operations, eventually leading to a total freeze of its business activities. The pattern of failing to pay regulatory fees and listing dues escalated into a formal delisting, while the Section 206 inquiry by the Ministry of Corporate Affairs uncovered systemic reporting violations that the company lacked the capital to remediate. As liquidity dried up, the inventory-heavy balance sheet proved illiquid, and the related-party advances were never recovered, leaving shareholders with a hollow shell that could no longer function as a going concern.
RichFakir rates Shukra Bullions Ltd's business quality as poor — 19/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Shukra Bullions Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Shukra Bullions Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Shukra Bullions Ltd's fair value is about ₹0 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →